| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xeris Biopharma Holdings, Inc. (XERS) has 11 insiders with recent SEC Form 4 filings, including 5 buys and 5 sells. XERS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 3.16M | $20.62M | - | |
| Other | 1.79M | $11.66M | - | |
| Other | 1.46M | $9.54M | - | |
| Other | 1.19M | $7.79M | -16,667 | |
| Dir | 698.1K | $4.56M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | Persky Marla | Director | Sell | 15,500 | $7.72 | $119,610.40 | -9.8% | -9.6% | - | |
| Aug 28, 2025 | Sherman Jeffrey W | Director | Sale+OE | 42,232 | $7.92 | $334,515.45 | -16.2% | -9.1% | - | |
| Aug 13, 2025 | Johnson John49 | Director | Sell | 107,500 | $7.32 | $786,459.25 | -11.4% | +2.2% | - | |
| Aug 12, 2025 | Halkuff Dawn | Director | Sell | 42,500 | $7.28 | $309,225.75 | -27.0% | +5.8% | - | |
| Jun 13, 2025 | McCulloch Kevin | See Remarks | Buy | 25,000 | $4.38 | $109,475.00 | +1.5% | +76.6% | - | |
| Mar 20, 2025 | Hecht Beth45 | See Remarks | Sell | 40,000 | $5.43 | $217,244.00 | -2.9% | -15.7% | +0.2% | |
| Aug 12, 2024 | Schmid John P.80 | Director | Buy | 4,515 | $2.25 | $10,147.01 | +21.8% | +45.8% | +224.4% | |
| Aug 9, 2024 | Schmid John P.80 | Director | Buy | 4,285 | $2.37 | $10,134.03 | +26.1% | +44.8% | +194.8% | |
| May 10, 2024 | Schmid John P.80 | Director | Buy | 5,400 | $1.91 | $10,314.00 | +49.1% | +26.7% | +184.7% | |
| Mar 14, 2024 | Schmid John P.80 | Director | Buy | 4,500 | $2.16 | $9,720.00 | +69.2% | +5.2% | +126.3% |